540359 — Parmax Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.68bn
- IN₹1.74bn
- IN₹110.53m
Annual cashflow statement for Parmax Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | ARS | ARS |
| Standards: | IAS | IAS |
| Status: | Final | Final |
| Net Income/Starting Line | 0.461 | -56.6 |
| Depreciation | ||
| Non-Cash Items | -1.85 | 0 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -14.1 | 37.5 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Other Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | 3.33 | -1.9 |
| Capital Expenditures | -9.36 | -15.9 |
| Purchase of Fixed Assets | ||
| Cash from Investing Activities | -9.36 | -15.9 |
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | -0.442 | 14.3 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -6.47 | -3.5 |